TuHURA files IND for cancer treatment TBS-2025
TuHURA Biosciences (NASDAQ:HURA) announced today that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to advance its TBS-2025 therapy.
Todas as matérias desta categoria, das mais recentes às mais antigas.
TuHURA Biosciences (NASDAQ:HURA) announced today that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to advance its TBS-2025 therapy.
Paranovus Entertainment Technology (NASDAQ:PAVS) executed a non-binding letter of intent to acquire Jabanero for a proposed all-cash purchase price of $15 million to $20 million.
Jerash Holdings (NASDAQ:JRSH) reported record full-year fiscal 2026 revenue of $166.3 million following a 46.6% surge in fourth-quarter sales.
Alkermes plc (NASDAQ:ALKS) announced that its investigational oral medication, alixorexton, was granted orphan drug designations by regulatory authorities in the United States and Europe for rare sleep disorders.
The US and Iran said they reached an interim agreement to reopen the Strait of Hormuz, setting the stage for 60 days of negotiations on the fate of Tehran's nuclear program. Officials from the two countries will meet in Switzerland on June 19 to formally sign the agreement. Bloomberg's Tyler Kendall reports.
IREN (NASDAQ:IREN), a leading vertically integrated AI Cloud infrastructure provider, today announced the formal completion of its acquisition of Ingenostrum, S.L., widely known as Nostrum Group.
Coda Octopus Group (NASDAQ:CODA) reported its fiscal second-quarter 2026 financial results for the period ended April 30, 2026.
Tripadvisor (NASDAQ:TRIP) executed a put option agreement to sell its European online restaurant reservation and management platform, TheFork, to American Express (NYSE:AXP) for $700 million in cash.
Generac Holdings (NYSE:GNRC) has finalized the acquisition of a new manufacturing facility in Belvidere, Illinois.
Rocket Lab President and CEO Peter Beck says attention generated by the record SpaceX IPO "is a good thing for the whole space industry," as he discusses the race to raise capital in the industry and the potential timeline for data centers in space. Beck speaks on "Bloomberg Surveillance."
Honeywell (NASDAQ:HON) has greenlit a structural corporate split, separating its high-performing aerospace operations from its automation and software assets.
Canopy Growth (TSX:WEED) (NASDAQ:CGC) delivered a mixed but structurally stronger fiscal 2026 financial report, showcasing accelerating top-line momentum in its core cannabis business alongside major balance sheet repair.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade